Digital Therapeutics (DTx) Market Size, Share & Growth Graph by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Digital Therapeutics (DTx) Market Size Analysis

Global Digital Therapeutics (DTx) Market Introduction
By Offering
1. Introduction
  1. Offering By Value
2. Devices
  1. By Value
3. Software
  1. By Value
4. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Treatment
  1. By Value
3. Diabetes
  1. By Value
4. CNS Disorders
  1. By Value
5. Chronic Respiratory Diseases
  1. By Value
6. Musculoskeletal Diseases
  1. By Value
7. Cardiovascular Diseases
  1. By Value
8. Medication Adherence
  1. By Value
9. Smoking Cessation
  1. By Value
10. Rehabilitation & Patient Care
  1. By Value
11. Other Application
  1. By Value
12. Preventive
  1. By Value
13. Obesity
  1. By Value
14. Nutrition
  1. By Value
15. Lifecycle Management
  1. By Value
By Revenue Model
1. Introduction
  1. Revenue Model By Value
2. Subscription-based
  1. By Value
3. One-Time Purchase
  1. By Value
4. Outcome-based
  1. By Value

North America Market Analysis

Introduction
By Offering
1. Introduction
  1. Offering By Value
2. Devices
  1. By Value
3. Software
  1. By Value
4. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Treatment
  1. By Value
3. Diabetes
  1. By Value
4. CNS Disorders
  1. By Value
5. Chronic Respiratory Diseases
  1. By Value
6. Musculoskeletal Diseases
  1. By Value
7. Cardiovascular Diseases
  1. By Value
8. Medication Adherence
  1. By Value
9. Smoking Cessation
  1. By Value
10. Rehabilitation & Patient Care
  1. By Value
11. Other Application
  1. By Value
12. Preventive
  1. By Value
13. Obesity
  1. By Value
14. Nutrition
  1. By Value
15. Lifecycle Management
  1. By Value
By Revenue Model
1. Introduction
  1. Revenue Model By Value
2. Subscription-based
  1. By Value
3. One-Time Purchase
  1. By Value
4. Outcome-based
  1. By Value
U.S.
1. By Offering
  1. Introduction
    1. Offering By Value
  2. Devices
    1. By Value
  3. Software
    1. By Value
  4. Services
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Treatment
    1. By Value
  3. Diabetes
    1. By Value
  4. CNS Disorders
    1. By Value
  5. Chronic Respiratory Diseases
    1. By Value
  6. Musculoskeletal Diseases
    1. By Value
  7. Cardiovascular Diseases
    1. By Value
  8. Medication Adherence
    1. By Value
  9. Smoking Cessation
    1. By Value
  10. Rehabilitation & Patient Care
    1. By Value
  11. Other Application
    1. By Value
  12. Preventive
    1. By Value
  13. Obesity
    1. By Value
  14. Nutrition
    1. By Value
  15. Lifecycle Management
    1. By Value
3. By Revenue Model
  1. Introduction
    1. Revenue Model By Value
  2. Subscription-based
    1. By Value
  3. One-Time Purchase
    1. By Value
  4. Outcome-based
    1. By Value
Canada

Europe Market Analysis

Introduction
By Offering
1. Introduction
  1. Offering By Value
2. Devices
  1. By Value
3. Software
  1. By Value
4. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Treatment
  1. By Value
3. Diabetes
  1. By Value
4. CNS Disorders
  1. By Value
5. Chronic Respiratory Diseases
  1. By Value
6. Musculoskeletal Diseases
  1. By Value
7. Cardiovascular Diseases
  1. By Value
8. Medication Adherence
  1. By Value
9. Smoking Cessation
  1. By Value
10. Rehabilitation & Patient Care
  1. By Value
11. Other Application
  1. By Value
12. Preventive
  1. By Value
13. Obesity
  1. By Value
14. Nutrition
  1. By Value
15. Lifecycle Management
  1. By Value
By Revenue Model
1. Introduction
  1. Revenue Model By Value
2. Subscription-based
  1. By Value
3. One-Time Purchase
  1. By Value
4. Outcome-based
  1. By Value
U.K.
1. By Offering
  1. Introduction
    1. Offering By Value
  2. Devices
    1. By Value
  3. Software
    1. By Value
  4. Services
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Treatment
    1. By Value
  3. Diabetes
    1. By Value
  4. CNS Disorders
    1. By Value
  5. Chronic Respiratory Diseases
    1. By Value
  6. Musculoskeletal Diseases
    1. By Value
  7. Cardiovascular Diseases
    1. By Value
  8. Medication Adherence
    1. By Value
  9. Smoking Cessation
    1. By Value
  10. Rehabilitation & Patient Care
    1. By Value
  11. Other Application
    1. By Value
  12. Preventive
    1. By Value
  13. Obesity
    1. By Value
  14. Nutrition
    1. By Value
  15. Lifecycle Management
    1. By Value
3. By Revenue Model
  1. Introduction
    1. Revenue Model By Value
  2. Subscription-based
    1. By Value
  3. One-Time Purchase
    1. By Value
  4. Outcome-based
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Offering
1. Introduction
  1. Offering By Value
2. Devices
  1. By Value
3. Software
  1. By Value
4. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Treatment
  1. By Value
3. Diabetes
  1. By Value
4. CNS Disorders
  1. By Value
5. Chronic Respiratory Diseases
  1. By Value
6. Musculoskeletal Diseases
  1. By Value
7. Cardiovascular Diseases
  1. By Value
8. Medication Adherence
  1. By Value
9. Smoking Cessation
  1. By Value
10. Rehabilitation & Patient Care
  1. By Value
11. Other Application
  1. By Value
12. Preventive
  1. By Value
13. Obesity
  1. By Value
14. Nutrition
  1. By Value
15. Lifecycle Management
  1. By Value
By Revenue Model
1. Introduction
  1. Revenue Model By Value
2. Subscription-based
  1. By Value
3. One-Time Purchase
  1. By Value
4. Outcome-based
  1. By Value
China
1. By Offering
  1. Introduction
    1. Offering By Value
  2. Devices
    1. By Value
  3. Software
    1. By Value
  4. Services
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Treatment
    1. By Value
  3. Diabetes
    1. By Value
  4. CNS Disorders
    1. By Value
  5. Chronic Respiratory Diseases
    1. By Value
  6. Musculoskeletal Diseases
    1. By Value
  7. Cardiovascular Diseases
    1. By Value
  8. Medication Adherence
    1. By Value
  9. Smoking Cessation
    1. By Value
  10. Rehabilitation & Patient Care
    1. By Value
  11. Other Application
    1. By Value
  12. Preventive
    1. By Value
  13. Obesity
    1. By Value
  14. Nutrition
    1. By Value
  15. Lifecycle Management
    1. By Value
3. By Revenue Model
  1. Introduction
    1. Revenue Model By Value
  2. Subscription-based
    1. By Value
  3. One-Time Purchase
    1. By Value
  4. Outcome-based
    1. By Value
Korea
Japan
India
Australia
Singapore
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Offering
1. Introduction
  1. Offering By Value
2. Devices
  1. By Value
3. Software
  1. By Value
4. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Treatment
  1. By Value
3. Diabetes
  1. By Value
4. CNS Disorders
  1. By Value
5. Chronic Respiratory Diseases
  1. By Value
6. Musculoskeletal Diseases
  1. By Value
7. Cardiovascular Diseases
  1. By Value
8. Medication Adherence
  1. By Value
9. Smoking Cessation
  1. By Value
10. Rehabilitation & Patient Care
  1. By Value
11. Other Application
  1. By Value
12. Preventive
  1. By Value
13. Obesity
  1. By Value
14. Nutrition
  1. By Value
15. Lifecycle Management
  1. By Value
By Revenue Model
1. Introduction
  1. Revenue Model By Value
2. Subscription-based
  1. By Value
3. One-Time Purchase
  1. By Value
4. Outcome-based
  1. By Value
UAE
1. By Offering
  1. Introduction
    1. Offering By Value
  2. Devices
    1. By Value
  3. Software
    1. By Value
  4. Services
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Treatment
    1. By Value
  3. Diabetes
    1. By Value
  4. CNS Disorders
    1. By Value
  5. Chronic Respiratory Diseases
    1. By Value
  6. Musculoskeletal Diseases
    1. By Value
  7. Cardiovascular Diseases
    1. By Value
  8. Medication Adherence
    1. By Value
  9. Smoking Cessation
    1. By Value
  10. Rehabilitation & Patient Care
    1. By Value
  11. Other Application
    1. By Value
  12. Preventive
    1. By Value
  13. Obesity
    1. By Value
  14. Nutrition
    1. By Value
  15. Lifecycle Management
    1. By Value
3. By Revenue Model
  1. Introduction
    1. Revenue Model By Value
  2. Subscription-based
    1. By Value
  3. One-Time Purchase
    1. By Value
  4. Outcome-based
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Offering
1. Introduction
  1. Offering By Value
2. Devices
  1. By Value
3. Software
  1. By Value
4. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Treatment
  1. By Value
3. Diabetes
  1. By Value
4. CNS Disorders
  1. By Value
5. Chronic Respiratory Diseases
  1. By Value
6. Musculoskeletal Diseases
  1. By Value
7. Cardiovascular Diseases
  1. By Value
8. Medication Adherence
  1. By Value
9. Smoking Cessation
  1. By Value
10. Rehabilitation & Patient Care
  1. By Value
11. Other Application
  1. By Value
12. Preventive
  1. By Value
13. Obesity
  1. By Value
14. Nutrition
  1. By Value
15. Lifecycle Management
  1. By Value
By Revenue Model
1. Introduction
  1. Revenue Model By Value
2. Subscription-based
  1. By Value
3. One-Time Purchase
  1. By Value
4. Outcome-based
  1. By Value
Brazil
1. By Offering
  1. Introduction
    1. Offering By Value
  2. Devices
    1. By Value
  3. Software
    1. By Value
  4. Services
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Treatment
    1. By Value
  3. Diabetes
    1. By Value
  4. CNS Disorders
    1. By Value
  5. Chronic Respiratory Diseases
    1. By Value
  6. Musculoskeletal Diseases
    1. By Value
  7. Cardiovascular Diseases
    1. By Value
  8. Medication Adherence
    1. By Value
  9. Smoking Cessation
    1. By Value
  10. Rehabilitation & Patient Care
    1. By Value
  11. Other Application
    1. By Value
  12. Preventive
    1. By Value
  13. Obesity
    1. By Value
  14. Nutrition
    1. By Value
  15. Lifecycle Management
    1. By Value
3. By Revenue Model
  1. Introduction
    1. Revenue Model By Value
  2. Subscription-based
    1. By Value
  3. One-Time Purchase
    1. By Value
  4. Outcome-based
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Digital Therapeutics (DTx) Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Noom, Inc.
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Teladoc Health
Omada Health, Inc.
Pear Therapeutics
Medtronic
ResMed Inc.
Welldoc, Inc.
Biofourmis
Better Therapeutics, Inc.
Click Therapeutics, Inc.
Akili Interactive, Inc.
Canary Health, Inc.
Virta Health Corp.
Mindable Health GmbH
Ayogo
Ultrahuman
Headspace Health
Rewire DTX
Hinge Health, Inc.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment